These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 14571790

  • 1. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q, Tang ZY, Qin LX, Ma ZC, Zhang LH.
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [Abstract] [Full Text] [Related]

  • 2. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
    Pang JZ, Qin LX, Wang QQ, Ren N, Sun BS, Lin GL, Ye QH, Liu YK, Tang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
    [Abstract] [Full Text] [Related]

  • 3. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q.
    ANZ J Surg; 2009 Dec; 79(1-2):62-9. PubMed ID: 19183381
    [Abstract] [Full Text] [Related]

  • 4. [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma].
    Niu Q, Tang Z, Ma Z, Qin L, Bao W, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():58-60. PubMed ID: 11509142
    [Abstract] [Full Text] [Related]

  • 5. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
    Wang B, Xia CY, Lau WY, Lu XY, Dong H, Yu WL, Jin GZ, Cong WM, Wu MC.
    J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
    [Abstract] [Full Text] [Related]

  • 6. [The relationship between nm23-H1 loss of heterozygosity and metastasis in hepatocellular carcinoma].
    Ye Y, Yu Y, Wan D, Tang Z, Lu J, He L.
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):161-3. PubMed ID: 11825358
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
    Shirabe K, Wakiyama S, Gion T, Motomura K, Koyanagi T, Sakamoto S, Nagaie T.
    Hepatogastroenterology; 2007 Mar; 54(79):2084-7. PubMed ID: 18251164
    [Abstract] [Full Text] [Related]

  • 8. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
    Takada Y, Otsuka M, Todoroki T, Fukao K.
    Hepatogastroenterology; 2003 Mar; 50(54):1991-5. PubMed ID: 14696450
    [Abstract] [Full Text] [Related]

  • 9. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK, Tang ZY.
    Clin Cancer Res; 2007 Dec 15; 13(24):7363-9. PubMed ID: 18094418
    [Abstract] [Full Text] [Related]

  • 10. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
    Pang JZ, Qin LX, Ren N, Ye QH, Ying WD, Liu YK, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1662-5. PubMed ID: 16854315
    [Abstract] [Full Text] [Related]

  • 11. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
    Li S, Wang H, Zhang C.
    Zhonghua Yi Xue Za Zhi; 2000 Aug 27; 80(8):577-81. PubMed ID: 11798820
    [Abstract] [Full Text] [Related]

  • 12. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N, Hanazaki K.
    J Am Coll Surg; 2004 Mar 27; 198(3):356-65. PubMed ID: 14992736
    [Abstract] [Full Text] [Related]

  • 13. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW, Finkelstein SD, Demetris AJ, Swalsky PA, Sasatomi E, Bandos A, Subotin M, Dvorchik I.
    Liver Transpl; 2003 Jul 27; 9(7):664-71. PubMed ID: 12827550
    [Abstract] [Full Text] [Related]

  • 14. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma].
    Wu X, Lin Z, Fan J, Lu J, Wang L, Tang Z.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun 27; 10(3):189-91. PubMed ID: 12113675
    [Abstract] [Full Text] [Related]

  • 15. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.
    Ann Surg; 2006 Sep 27; 244(3):451-63. PubMed ID: 16926571
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma.
    Utsunomiya T, Shimada M, Shirabe K, Kajiyama K, Gion T, Takenaka K, Sugimachi K.
    Hepatogastroenterology; 2001 Sep 27; 48(40):1088-93. PubMed ID: 11490807
    [Abstract] [Full Text] [Related]

  • 17. Hepatic resection for hepatocellular carcinoma in elderly patients.
    Yeh CN, Lee WC, Jeng LB, Chen MF.
    Hepatogastroenterology; 2004 Sep 27; 51(55):219-23. PubMed ID: 15011868
    [Abstract] [Full Text] [Related]

  • 18. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
    Cui BK, Zhang CQ, Zhang Y, Yuan YF, Zhang YQ, Shi M, Chen MS, Li SP, Li JQ.
    Ai Zheng; 2006 Jul 27; 25(7):876-9. PubMed ID: 16831281
    [Abstract] [Full Text] [Related]

  • 19. Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.
    O'Connell P, Fischbach K, Hilsenbeck S, Mohsin SK, Fuqua SA, Clark GM, Osborne CK, Allred DC.
    J Natl Cancer Inst; 1999 Aug 18; 91(16):1391-7. PubMed ID: 10451444
    [Abstract] [Full Text] [Related]

  • 20. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.
    Tang Z, Zhou X, Lin Z, Yang B, Ma Z, Ye S, Wu Z, Fan J, Liu Y, Liu K, Qin L, Tian J, Sun H, He B, Xia J, Qiu S, Zhou J.
    Chin Med J (Engl); 1999 Oct 18; 112(10):887-91. PubMed ID: 11717970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.